BeiGene to Present at the Goldman Sachs 45th Annual Global Healthcare Conference

Rhea-AI Summary

BeiGene, a global oncology company, announced its participation in the Goldman Sachs 45th Annual Global Healthcare Conference on June 11, 2024. The event will feature a fireside chat at 1:20 pm EDT, accessible via live webcast through BeiGene's investor relations websites. The replay will be available for 180 days post-event.

Positive

• Participation in the Goldman Sachs 45th Annual Global Healthcare Conference highlights BeiGene’s recognition in the global healthcare industry.
• The event's webcast accessibility provides transparency and better investor engagement, potentially enhancing investor confidence.

Negative

• No concrete financial data or clinical updates are included in the announcement, which may leave investors seeking more substantive information.
• immediate impact on stock price as the announcement focuses on future participation in an event rather than tangible business developments.

SAN MATEO, Calif.--(BUSINESS WIRE)-- BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global oncology company, today announced the Company will participate in the Goldman Sachs 45th Annual Global Healthcare Conference on Tuesday, June 11, 2024 with a fireside chat at 1:20 pm EDT.

Live webcast of this event can be accessed from the investors section of BeiGene’s website at http://ir.beigene.com, https://hkexir.beigene.com/, https://sseir.beigene.com/. Archived replay will be available for 180 days following the event.

About BeiGene

BeiGene is a global oncology company that is discovering and developing innovative treatments that are more accessible and affordable to cancer patients worldwide. With a broad portfolio, we are expediting development of our diverse pipeline of novel therapeutics through our internal capabilities and collaborations. We are committed to radically improving access to medicines for far more patients who need them. Our growing global team of more than 10,000 colleagues spans five continents. To learn more about BeiGene, please visit www.beigene.com and follow us on LinkedIn, X (formerly known as Twitter) and Facebook.

Forward-Looking Statements

This presentation may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 and other federal securities laws, including statements regarding BeiGene's plans, commitments, aspirations and goals related to BeiGene’s medicines and drug candidates. Actual results may differ materially from those indicated in the forward-looking statements as a result of various important factors which are discussed in the section entitled “Risk Factors” in BeiGene’s most recent quarterly report on Form 10-Q filed with the U.S. Securities and Exchange Commission (“SEC”) as well as discussions of potential risks, uncertainties, and other important factors in BeiGene's subsequent filings with the SEC. All information in this presentation is as of the date presented, and BeiGene undertakes no duty to update such information unless required by law.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240604005765/en/

Investors:

Liza Heapes

+1 857-302-5663

ir@beigene.com

Media:

Kyle Blankenship

+1 667-351-5176

media@beigene.com

Source: BeiGene, Ltd.

FAQ

When will BeiGene participate in the Goldman Sachs 45th Annual Global Healthcare Conference?

BeiGene will participate on June 11, 2024.

What will BeiGene present at the Goldman Sachs Healthcare Conference?

BeiGene will feature a fireside chat at 1:20 pm EDT.

How can one access the BeiGene presentation at the Goldman Sachs Healthcare Conference?

The presentation can be accessed via live webcast on BeiGene's investor relations websites.

How long will the replay of BeiGene's presentation be available?

The replay will be available for 180 days following the event.

What is the stock symbol for BeiGene?

BeiGene's stock symbols are NASDAQ: BGNE, HKEX: 06160, and SSE: 688235.